Back to Search
Start Over
Nanoparticle formulation increasesSyzygium cuminiantioxidant activity inCandida albicans-infected diabetic rats
- Source :
- Pharmaceutical Biology, Vol 55, Iss 1, Pp 1082-1088 (2017)
- Publication Year :
- 2017
- Publisher :
- Informa UK Limited, 2017.
-
Abstract
- Context: Syzygium cumini (L.) Skeels (Myrtaceae) is a medicinal plant widely used in folk medicine for the treatment of diabetes mellitus (DM). However, studies on the use of this plant and of nanoparticle formulations against DM-related fungal infections are scarce. Objective: To evaluate the effect of the treatments with aqueous seed extract of S. cumini (ASc) and ASc-loaded polymeric nanoparticles (NPASc) on biochemical parameters in Candida albicans-infected diabetic rats. Materials and methods: Male Wistar rats were divided into eight groups: Control, DM, C. albicans, C. albicans + ASc, C. albicans + NPASc, DM + C. albicans, DM + C. albicans + ASc and DM + C. albicans + NPASc. Rats were daily treated with ASc or NPASc (100 mg/kg) for 21 days. Biochemical parameters in serum and urine, advanced oxidation protein product (AOPP) and TBARS levels in the serum, kidney, liver and pancreas and N-acetyl-β-d-glucosaminidase (NAG) activities in kidney and urine were evaluated. Results: Biochemical and oxidative stress parameters increased in rats with DM and/or candidiasis. NPASc was more effective than ASc in decreasing glucose (56%), cholesterol (33%) and creatinine (51%) levels; serum (16%) and pancreatic (46%) AOPP and renal (48%) TBARS levels when compared with DM + C. albicans group. In C. albicans group, both treatments decreased NAG activity but did not decrease creatinine levels. Conclusions: These data suggest that the use of nanotechnology is able to improve plant extract properties such as antioxidant activity that may be useful in diabetes-related complications.
- Subjects :
- Male
0301 basic medicine
Antifungal Agents
Antioxidant
Syzygium
medicine.medical_treatment
Pharmaceutical Science
02 engineering and technology
Pharmacology
Kidney
Antioxidants
chemistry.chemical_compound
Candida albicans
Drug Discovery
diabetic complications
n-acetyl-β-d-glucosaminidase
biology
Chemistry
Candidiasis
General Medicine
021001 nanoscience & nanotechnology
animal models
Corpus albicans
Liver
Biochemistry
tbars
Seeds
Molecular Medicine
0210 nano-technology
medicine.drug
Drug Compounding
advanced oxidation protein product
Context (language use)
streptozotocin
Streptozocin
Diabetes Mellitus, Experimental
03 medical and health sciences
Diabetes mellitus
medicine
TBARS
Animals
Rats, Wistar
Pancreas
Creatinine
Plants, Medicinal
Plant Extracts
lcsh:RM1-950
medicine.disease
Streptozotocin
biology.organism_classification
Oxidative Stress
Diabetes Mellitus, Type 1
lcsh:Therapeutics. Pharmacology
030104 developmental biology
Complementary and alternative medicine
Solvents
Nanoparticles
Biomarkers
Phytotherapy
Subjects
Details
- ISSN :
- 17445116 and 13880209
- Volume :
- 55
- Database :
- OpenAIRE
- Journal :
- Pharmaceutical Biology
- Accession number :
- edsair.doi.dedup.....f29c49298a7e62f043fe213d8e9372e7
- Full Text :
- https://doi.org/10.1080/13880209.2017.1283338